Beijing Chunlizhengda Medical Instruments Co., Ltd. provided that for the six months ended 30 June 2018, the operating revenue is expected to record a significant increase by more than 50% as compared to that for the corresponding period of last year. The significant improvement in financial results was primary attributable to the company's continuous investment in the research and development, product quality and technology innovation, as well as devotion to product improvement and marketing activities, including academic promotion.